Intellijoint Surgical received FDA 510(k) clearance to market its intellijoint HIP® 3D Mini-Optical Navigation System for use in revision total hip replacement. This broadens the systems applications, adding to primary hip replacement in anterior, posterior and lateral surgical approaches.
intellijoint HIP requires no pre- or intra-op imaging, and can be used with any manufacturer’s implant. In revision surgery, the system allows existing components to be evaluated without removal, which can greatly reduce surgical risk and complications.
In early 2Q17, the intellijoint HIP system surpassed the milestone of >1,000 procedures performed throughout Australia, Canada and the U.S.
Intellijoint Surgical received FDA 510(k) clearance to market its intellijoint HIP® 3D Mini-Optical Navigation System for use in revision total hip replacement. This broadens the systems applications, adding to primary hip replacement in anterior, posterior and lateral surgical approaches.
intellijoint HIP requires no pre- or intra-op imaging,...
Intellijoint Surgical received FDA 510(k) clearance to market its intellijoint HIP® 3D Mini-Optical Navigation System for use in revision total hip replacement. This broadens the systems applications, adding to primary hip replacement in anterior, posterior and lateral surgical approaches.
intellijoint HIP requires no pre- or intra-op imaging, and can be used with any manufacturer’s implant. In revision surgery, the system allows existing components to be evaluated without removal, which can greatly reduce surgical risk and complications.
In early 2Q17, the intellijoint HIP system surpassed the milestone of >1,000 procedures performed throughout Australia, Canada and the U.S.
Copy to clipboard 
